10-K Filing

TYME TECHNOLOGIES, INC. CIK: 1537917 FY 2020

Filing Information

Form Type	10-K
Accession Number	`0001564590-21-032445`
Period End Date	20210331
Filing Date	20210610
Fiscal Year	2020
Fiscal Period	FY
XBRL Instance	tyme-20210331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 64 Income Statement 27 Cash Flow Statement 44 Stockholders Equity 19

Balance Sheet 64 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$107.52M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$26.70M	USD	Point-in-time
Prepaid clinical costs	`PrepaidClinicalCostsCurrent`	$396.96K	USD	Point-in-time
Prepaid clinical costs	`PrepaidClinicalCostsCurrent`	$987.47K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$981.95K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.15M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$28.08M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$109.66M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.18K	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid clinical costs, net of current portion	`PrepaidClinicalCostsNoncurrent`	$1.27M	USD	Point-in-time
Prepaid clinical costs, net of current portion	`PrepaidClinicalCostsNoncurrent`	$530.99K	USD	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$75.47K	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$150.30K	USD	Point-in-time
Total assets	`Assets`	$29.50M	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total assets	`Assets`	$110.26M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	172.20M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	123.31M	shares	Point-in-time
Accounts payable and other current liabilities (including $87,000 and $73,000 of related party accounts payable, respectively)	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$3.84M	USD	Point-in-time
Accounts payable and other current liabilities (including $87,000 and $73,000 of related party accounts payable, respectively)	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$2.83M	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	172.20M	shares	Point-in-time
Severance payable	`SeverancePayableCurrent`	$726.03K	USD	Point-in-time
Severance payable	`SeverancePayableCurrent`	$380.72K	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	123.31M	shares	Point-in-time
Accrued bonuses	`EmployeeRelatedLiabilitiesCurrent`	$1.80M	USD	Point-in-time
Accrued bonuses	`EmployeeRelatedLiabilitiesCurrent`	$1.04M	USD	Point-in-time
Insurance note payable	`NotesPayableCurrent`	$518.12K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityCurrent`	$54.66K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityCurrent`	$34.66K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.58M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.64M	USD	Point-in-time
Severance payable, net of current portion	`SeverancePayableNoncurrent`	$1.25M	USD	Point-in-time
Severance payable, net of current portion	`SeverancePayableNoncurrent`	$850.71K	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$41.26K	USD	Point-in-time
Warrant liability	`WarrantLiabilityNoncurrent`	$3.64M	USD	Point-in-time
Warrant liability	`WarrantLiabilityNoncurrent`	$1.93M	USD	Point-in-time
Total liabilities	`Liabilities`	$8.47M	USD	Point-in-time
Total liabilities	`Liabilities`	$10.48M	USD	Point-in-time
Commitments and contingencies (See Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (See Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value, 300,000,000 shares authorized, 172,200,644 issued and outstanding at March 31, 2021, and 300,000,000 authorized, 123,312,252 issued and outstanding at March 31, 2020	`CommonStockValue`	$17.22K	USD	Point-in-time
Common stock, $0.0001 par value, 300,000,000 shares authorized, 172,200,644 issued and outstanding at March 31, 2021, and 300,000,000 authorized, 123,312,252 issued and outstanding at March 31, 2020	`CommonStockValue`	$12.33K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$238.57M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$126.83M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-136.79M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-107.82M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$19.03M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$9.67M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$101.80M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$110.26M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$29.50M	USD	Point-in-time

Income Statement 27 line items

Line Item	Tag	Value	Unit	Period
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$517.00K	USD	Annual
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$447.00K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$12.96M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$17.03M	USD	Annual
General and administrative (including $517,000 and $447,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$10.19M	USD	Annual
General and administrative (including $517,000 and $447,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$12.80M	USD	Annual
Total operating expenses	`OperatingExpenses`	$25.76M	USD	Annual
Total operating expenses	`OperatingExpenses`	$27.22M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-25.76M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-27.22M	USD	Annual
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-3.64M	USD	Annual
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$3.92M	USD	Annual
Gain on warrant exchange	`GainLossOnWarrantExchange`	$2.23M	USD	Annual
Interest income	`InvestmentIncomeInterest`	$22.08K	USD	Annual
Interest income	`InvestmentIncomeInterest`	$229.46K	USD	Annual
Interest expense	`InterestExpense`	$97.13K	USD	Annual
Interest expense	`InterestExpense`	$114.24K	USD	Annual
Total other income (expenses)	`NonoperatingIncomeExpense`	$-1.76M	USD	Annual
Total other income (expenses)	`NonoperatingIncomeExpense`	$3.76M	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-28.98M	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-22.00M	USD	Annual
Net loss	`NetIncomeLoss`	$-28.98M	USD	Annual
Net loss	`NetIncomeLoss`	$-22.00M	USD	Annual
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.22	USD	Annual
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.19	USD	Annual
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	134.25M	shares	Annual
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	114.53M	shares	Annual

Cash Flow Statement 44 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-28.98M	USD	Annual
Net loss	`ProfitLoss`	$-22.00M	USD	Annual
Depreciation	`Depreciation`	$5.18K	USD	Annual
Depreciation	`Depreciation`	$5.18K	USD	Annual
Amortization of employees, directors and consultants stock options	`ShareBasedCompensation`	$6.09M	USD	Annual
Amortization of employees, directors and consultants stock options	`ShareBasedCompensation`	$3.46M	USD	Annual
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-3.64M	USD	Annual
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$3.92M	USD	Annual
Gain on warrant exchange	`GainLossOnWarrantExchange`	$2.23M	USD	Annual
Prepaid clinical costs	`IncreaseDecreaseInPrepaidClinicalCosts`	$-195.17K	USD	Annual
Prepaid clinical costs	`IncreaseDecreaseInPrepaidClinicalCosts`	$-144.53K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$171.02K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-538.07K	USD	Annual
Operating lease right-of-use asset	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-150.27K	USD	Annual
Operating lease right-of-use asset	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-297.60K	USD	Annual
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.02M	USD	Annual
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-865.01K	USD	Annual
Severance payable	`IncreaseDecreaseInSeverancePayable`	$-58.90K	USD	Annual
Severance payable	`IncreaseDecreaseInSeverancePayable`	$-428.24K	USD	Annual
Accrued bonuses	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$305.73K	USD	Annual
Accrued bonuses	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-760.27K	USD	Annual
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-54.19K	USD	Annual
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-49.33K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-23.56M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-19.56M	USD	Annual
Insurance note payments	`InsuranceNotePayments`	$597.34K	USD	Annual
Insurance note payments	`InsuranceNotePayments`	$518.12K	USD	Annual
Proceeds from registered offerings, net of issuance costs	`ProceedsFromIssuanceOfCommonStockAndWarrants`	$99.55M	USD	Annual
Proceeds from registered offerings, net of issuance costs	`ProceedsFromIssuanceOfCommonStockAndWarrants`	$32.56M	USD	Annual
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$5.35M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$104.38M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$31.96M	USD	Annual
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$12.40M	USD	Annual
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$80.82M	USD	Annual
Cash and cash equivalents beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$26.70M	USD	Point-in-time
Cash and cash equivalents beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$107.52M	USD	Point-in-time
Cash and cash equivalents beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$14.30M	USD	Point-in-time
Cash and cash equivalents end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$26.70M	USD	Point-in-time
Cash and cash equivalents end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$107.52M	USD	Point-in-time
Cash and cash equivalents end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$14.30M	USD	Point-in-time
Interest	`InterestPaidNet`	$97.13K	USD	Annual
Interest	`InterestPaidNet`	$114.24K	USD	Annual
Financing of insurance premiums	`FinancingOfInsurancePremiums`	$518.12K	USD	Annual
Operating lease right-of-use asset obtained in exchange for lease liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$75.44K	USD	Annual

Stockholders Equity 19 line items

Line Item	Tag	Value	Unit	Period
Warrants	`FairValueOfDerivativeLiabilityClassifiedAsWarrantsIssuedWithCommonStock`	$7.28M	USD	Annual
Balance, at beginning	`StockholdersEquity`	$19.03M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$9.67M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$101.80M	USD	Point-in-time
Balance, at beginning (in shares)	`CommonStockSharesOutstanding`	172.20M	shares	Point-in-time
Balance, at beginning (in shares)	`CommonStockSharesOutstanding`	123.31M	shares	Point-in-time
Proceeds from the exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$5.35M	USD	Annual
Proceeds from the exercise of stock options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	0.00	shares	Annual
Proceeds from the exercise of stock options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	2.03M	shares	Annual
Warrant to share exchange	`StockIssuedDuringPeriodValueWarrantToShareExchange`	$3.39M	USD	Annual
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$3.46M	USD	Annual
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$6.09M	USD	Annual
Net loss	`NetIncomeLoss`	$-28.98M	USD	Annual
Net loss	`NetIncomeLoss`	$-22.00M	USD	Annual
Balance, at end	`StockholdersEquity`	$19.03M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$9.67M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$101.80M	USD	Point-in-time
Balance, at end (in shares)	`CommonStockSharesOutstanding`	172.20M	shares	Point-in-time
Balance, at end (in shares)	`CommonStockSharesOutstanding`	123.31M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.